The estimated Net Worth of Paul Marshall is at least $3.98 millier dollars as of 21 March 2016. Paul Marshall owns over 1,100 units of Heron Therapeutics Inc stock worth over $3,982 and over the last 10 years Paul sold HRTX stock worth over $0.
Paul has made over 4 trades of the Heron Therapeutics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Paul exercised 1,100 units of HRTX stock worth $9,955 on 21 March 2016.
The largest trade Paul's ever made was exercising 70,000 units of Heron Therapeutics Inc stock on 5 March 2015 worth over $658,000. On average, Paul trades about 12,217 units every 64 days since 2014. As of 21 March 2016 Paul still owns at least 2,200 units of Heron Therapeutics Inc stock.
You can see the complete history of Paul Marshall stock trades at the bottom of the page.
Paul's mailing address filed with the SEC is 123 SAGINAW DRIVE, , REDWOOD CITY, CA, 94063.
Over the last 11 years, insiders at Heron Therapeutics Inc have traded over $96,663,574 worth of Heron Therapeutics Inc stock and bought 6,549,746 units worth $56,275,132 . The most active insiders traders include Kevin Ctang Capital Managem..., Adam Morgan et Craig A Collard. On average, Heron Therapeutics Inc executives and independent directors trade stock every 30 days with the average trade being worth of $176,989. The most recent stock trade was executed by Craig A Collard on 19 July 2024, trading 13,797 units of HRTX stock currently worth $24,973.
heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
Heron Therapeutics Inc executives and other stock owners filed with the SEC include: